Literature DB >> 7029778

Antithrombotic activity of a polydeoxyribonucleotidic substance extracted from mammalian organs: a possible link with prostacyclin.

R Niada, M Mantovani, G Prino, R Pescador, F Berti, C Omini, G C Folco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7029778     DOI： 10.1016/0049-3848(81)90013-x

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  11 in total

Review 1.  The use of defibrotide in blood and marrow transplantation.

Authors:  Paul G Richardson; Enric Carreras; Massimo Iacobelli; Bijan Nejadnik
Journal:  Blood Adv       Date:  2018-06-26

2.  Acute effects of defibrotide, an experimental antithrombotic agent, on fibrinolysis and blood prostanoids in man.

Authors:  S Coccheri; G Biagi; C Legnani; B Bianchini; F Grauso
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Novel mechanism of action of a prostacyclin enhancing agent in haemorrhagic shock.

Authors:  H Bitterman; D J Lefer; A M Lefer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-06       Impact factor: 3.000

4.  Coronary endothelium-protective effects of defibrotide in ischaemia and reperfusion.

Authors:  A M Lefer; N Aoki; D Mulloy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

5.  New in vivo model to assess venous endothelial cell functions. Effect of defibrotide.

Authors:  T Di Perri; F Laghi Pasini; C Frigerio; P L Capecchi; G L Messa; M Franchi; F Landini; A Burresi; A Ghezzi; L Ceccatelli
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 6.  Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders.

Authors:  K J Palmer; K L Goa
Journal:  Drugs       Date:  1993-02       Impact factor: 9.546

7.  Defibrotide reduces infarct size in a rabbit model of experimental myocardial ischaemia and reperfusion.

Authors:  C Thiemermann; G R Thomas; J R Vane
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

8.  Effect of oral defibrotide on tissue-plasminogen activator and tissue-plasminogen activator inhibitor balance.

Authors:  F Violi; D Ferro; M Saliola; C Quintarelli; S Basili; F Balsano
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

9.  Selective stimulation of coronary vascular PGI2 but not of platelet thromboxane formation by defibrotide in the platelet perfused heart.

Authors:  P Löbel; K Schrör
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

10.  Treprostinil reduces endothelial damage in murine sinusoidal obstruction syndrome.

Authors:  Madeleine Themanns; Florian Koban; Christian Bergmayr; Alicja Chrzan; Wolfgang Strohmaier; Johannes Haybaeck; Michael Freissmuth; Eva Zebedin-Brandl
Journal:  J Mol Med (Berl)       Date:  2018-12-07       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.